Speaker Profile

Executive Summary：
Dr. Ming-Che Kuo is a distinguished neurologist and clinical scientist at the National Taiwan University Cancer Center. An expert in movement disorders, Dr. Kuo specializes in Parkinson’s disease (PD), Multiple System Atrophy (MSA), and Cerebellar Ataxia.

Dr. Kuo’s work is at the forefront of translational neurology, integrating neuroimaging, genomics, and multi-omic biomarkers to refine diagnostic accuracy and identify novel therapeutic targets. A prolific researcher, he has authored numerous high-impact publications in prestigious journals, including NPJ Digital Medicine and the Journal of Biomedical Science.

His pioneering contributions have earned multiple honors, including several National Innovation Awards and FutureTech Breakthrough Awards. Notably, his development of novel treatments for MSA provided the foundation for a biotechnology start-up currently conducting Phase II clinical trials worldwide. Beyond MSA, Dr. Kuo facilitates several landmark clinical trials for other rare diseases, including Spinocerebellar Ataxias (SCAs) and Amyotrophic Lateral Sclerosis (ALS).

His leadership extends across prominent medical organizations; he currently serves as the Director of the Society for Neurological Rare Diseases, Taiwan, and is the Secretary General of the Taiwan Brain Care Association.

Lecture Abstract：